AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection: a therapeutic dilemma in resource‐limited settings.

AIDS‐associated Cryptococcus neoformans and Penicillium marneffei coinfection has not been adequately studied and poses unique therapeutic challenges in resource‐limited settings. Itraconazole poorly penetrates the central nervous system, whereas fluconazole has poor activity against P. marneffei. We prospectively report management of 1 patient and retrospectively review 7 coinfection cases from Vietnam.

[1]  Philimon N. Gona,et al.  Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Jaffar,et al.  Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  A. Zolopa,et al.  Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial , 2009, PloS one.

[4]  E. Lanino,et al.  Voriconazole for Cryptococcal Meningitis in Children with Leukemia or Receiving Allogeneic Hemopoietic Stem Cell Transplant , 2009, Journal of chemotherapy.

[5]  S. Jaffar,et al.  Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  Daryl S Schiller,et al.  Posaconazole: an extended-spectrum triazole antifungal agent. , 2007, Clinical therapeutics.

[7]  H. Schlamm,et al.  Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. , 2007, The American journal of tropical medicine and hygiene.

[8]  P. Pitisuttithum,et al.  Activity of posaconazole in the treatment of central nervous system fungal infections. , 2005, The Journal of antimicrobial chemotherapy.

[9]  O. Kirk,et al.  Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy , 2002, Annals of Internal Medicine.

[10]  Alimuddin Zumla,et al.  Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions , 2001, Postgraduate medical journal.

[11]  K. Nelson,et al.  A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. , 1998, The New England journal of medicine.

[12]  K. Nelson,et al.  Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Saag,et al.  Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. , 1997, The New England journal of medicine.

[14]  S. Pauluzzi,et al.  High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  K. Nelson,et al.  Disseminated Penicillium marneffei infection in Southeast Asia , 1994, The Lancet.

[16]  K. Nelson,et al.  Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens , 1993, Antimicrobial Agents and Chemotherapy.

[17]  J. Scavone,et al.  Pharmacokinetics and bioavailability of fluconazole in patients with AIDS , 1993, Antimicrobial Agents and Chemotherapy.

[18]  R. Negroni,et al.  Itraconazole: pharmacokinetics and indications. , 1993, Archives of medical research.